Biomarkers sFlt and PlGF for diagnosis and therapy of pulmonaryhypertension

The present invention relates to the use of biomarkers sFlt and PlGF for diagnosis, early recognition and risk stratification of pulmonary hypertension. Thereby an immunologic test (ELISA) for the determination of blood levels of sFlt and PIGF in patients is preferred.

Further Information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0

Contact
Dr. Otmar Schöller

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Reconstructing plesiosaur swimming styles with bio-mimetic control

A research group may have unraveled the mystery behind the locomotion of the ancient marine reptile, the plesiosaur, by recreating a bio-inspired control system that accounts for motion adjustment. Extinct…

Kagome breaks the rules at record breaking temperatures

In case you’re scratching your head, we help break it down. Using muon spin rotation at the Swiss Muon Source SmS, researchers at PSI have discovered that a quantum phenomenon…

New findings on heart failure

Dysferlin protein protects and shapes the membrane of heart muscle cells. Researchers from the Heart Center of the University Medical Center Göttingen (UMG) led by Priv.-Doz. Dr Sören Brandenburg have…